Imidazole → HCID 9814917, compound

Imidazole (26.6 g, 0.39 mol) was dissolved in methylene chloride (400 mL) at room temperature. Iodine (102.5 g, 0.39 mol) was added and the reaction mixture was stirred for 10 min at room temperature and then cooled to 0° C. Triphenylphosphine (102.5 g, 0.39 mol) was added portionwise over 10 min such that the internal temperature remained below 10° C. A solution of tert-butyl (2R)-2-fluoro-3-hydroxypropylcarbamate (60.4 g, 0.31 mol) in methylene chloride (100 mL) was added dropwise. On completion of addition of tert-butyl (2R)-2-fluoro-3-hydroxypropylcarbamate, additional methylene chloride (200 mL) was added. The reaction mixture was allowed to warm to room temperature and stirring was continued for 17 h. The reaction mixture was filtered through a pad of Celite® (50 g) and washed with additional methylene chloride. The filtrate was concentrated under reduced pressure and purified by silica gel column chromatography eluting with methylene chloride. This procedure afforded tert-butyl (2R)-2-fluoro-3-iodopropylcarbamate as a white solid (64.7 g, 68%).

1. temperaturecooled to 0° C
2. customremained below 10° C
3. additionwas added
4. temperatureto warm to room temperature
5. stirringstirring
6. waitwas continued for 17 h
7. filtrationThe reaction mixture was filtered through a pad of Celite® (50 g)
8. washwashed with additional methylene chloride
9. concentrationThe filtrate was concentrated under reduced pressure
10. custompurified by silica gel column chromatography
11. washeluting with methylene chloride

ORD record

ord-b1699b3a770e46028d3d69e4375c8c9a

Source dataset

uspto-grants-2006_04

DOI

10.6084/m9.figshare.5104873.v1

Patent number

US07034176B2